TipRanks
AbbVie (ABBV)
NYSE:ABBV
US Market
ABBV
AbbVie
RESEARCH TOOLSreports
Want to see ABBV full AI Analyst Report?

AbbVie (ABBV) Stock News & Sentiment

24,282 Followers
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
Premium
Company Announcements
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
5d ago
ABBV
AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence
Premium
Company Announcements
AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence
7d ago
ABBV
AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline
Premium
Company Announcements
AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline
7d ago
ABBV
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
Premium
Ratings
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
9d ago
ABBV
Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO
Premium
Market News
Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO
16d ago
MS
JPM
AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update
Premium
Company Announcements
AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update
20d ago
ABBV
AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV
Premium
Company Announcements
AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV
26d ago
ABBV
More ABBV News >

ABBV News on the Web

AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?
Insider Monkey
Neutral
AbbVie, Genmab's Epcoritamab Plus R-CHOP Improves PFS & Cuts Progression Risk In Lymphoma
rttnews
Neutral
AbbVie Joins Federal 340B Rebate Pilot Program Ahead Of 2027 Launch
rttnews
Neutral
AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?
Insider Monkey
Bullish
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
The Motley Fool
Bullish
How to Create a Million-Dollar Stock Portfolio
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and AbbVie (ABBV)
TipRanks News
Bullish
AbbVie's Zumilokibart Phase 2 Success Highlights Dividend Sustainability Concerns (ABBV)
GuruFocus News
Neutral

News Score - Last 7 Days

Positive
ABBV
Sector Average
Media Buzz
This Week33 articles
Weekly Average29.75 articles
News Sentiment
This Week92%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ABBV’s Media Buzz Sentiment?
33 articles about ABBV were published this week. In an average week, 29.75 articles are published.
    What is ABBV’s weekly average amount of articles?
    In an average week, 29.75 articles about ABBV are published.
      What is ABBV’s News Sentiment?
      92% of articles about ABBV were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        REGNRegeneron
        QTTBQ32 Bio
        NVSNovartis
        RHHVFRoche Holding AG
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week